Single-cell technologies have contributed to unravelling tumour heterogeneity, now
considered a hallmark of cancer and one of the main causes of tumour resistance to cancer …

Circulating tumor cells (CTCs) play a causal role in the development of metastasis, the major
cause of cancer-associated mortality worldwide. In the past decade, the development of …

Background: Circulating tumour cells (CTC) in the blood have been accepted as a
prognostic marker in patients with metastatic colorectal cancer (CRC). Only limited data exist …

Abstract Background & Aims Liver transplantation (LTx) is one of the most effective
treatments for hepatocellular carcinoma (HCC); however, tumour recurrence after LTx often …

Increasing scientific evidences suggest that circulating tumor cells (CTC) in peripheral blood
may be a powerful predictor of survival in patients with pancreatic cancer. However, many …

Background The clinical significance of circulating tumour cells (CTCs) in limited-stage small-
cell lung cancer (LS-SCLC) is not well defined. We report a planned exploratory analysis of …

The detection of circulating tumor cells (CTCs) in the peripheral blood of metastatic breast
cancer (MBC) patients is an independent marker of prognosis. This large prospective …

The main issue concerning localized prostate cancers is the lack of a suitable marker which
could help patients' stratification at diagnosis and distinguish those with a benign disease …

Background Early detection of circulating tumor cells (CTCs) offers the possibility of
improved outcome for patients with head and neck squamous cell cancer (HNSCC) …

Circulating tumour cells (CTCs) and exosomes are promising circulating biomarkers. They
exist in easily accessible blood and carry large diversity of molecular information. As such …